 |
humanized IgG4 monoclonal antibody binding to human C1q |
|---|---|
| Trade Name | |
| Orphan Indication | Guillain-Barré syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-19 00:00:00 |
| Sponsor | Annexon Biosciences;280 Utah Avenue, Suite 110;South San Francisco, California, 94080 |
